Bill Detail

H.R. 11045

Congress: 119

Title

To amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.

Summary

No summary is available in Pulse’s cached record. Check Congress.gov for the official summary.

Sponsor

Rep. Josh Gottheimer [D-NJ-5]

Status

Referred to the House Committee on Energy and Commerce.

Status as of Nov 18, 2026, 4:34 AM · synced 9h ago

Introduced

2026-11-17

Data source mode: cache

Bill Engagement

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Pulse currently has no matching linked lobbying filings for this bill and Congress. Federal Intelligence provides the broader research platform; purchasing access does not guarantee missing records or a bespoke bill watch.

Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.

SEE A FINISHED HEALTHCARE EXAMPLE

Three days of Hill visits. Two Medicare access questions.

A separate, source-linked editorial example—not a dossier about this bill, an endorsement, or a claim of participation. The full records stay paid.

Read the finished healthcare brief →
Buy Federal Intelligence · $2,500 for 3 monthsPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.